Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study.
Jürgen BraunXenofon BaraliakosAtul A DeodharDominique BaetenJoachim SieperPaul EmeryAimee ReadieRuvie MartinShephard MpofuHanno B Richardsnull nullPublished in: Annals of the rheumatic diseases (2016)
NCT01358175.